Chemotherapy-related oral mucositis in breast cancer patients: a brief review
DOI:
https://doi.org/10.33448/rsd-v10i3.13338Keywords:
Stomatitis; Breast neoplasms; Chemotherapy; Antineoplastic agents.Abstract
Breast cancer can impact different health spheres of patients, since the experience with the treatment is often surrounded by fears and anxieties. It is possible to observe that adverse effects of chemotherapy are common and women with breast cancer may have a high incidence of oral mucositis (OM). Thus, the objective of this review was to discuss the relationship between chemotherapy treatment of breast cancer and the occurrence of oral mucositis. OM is characterized by the appearance of erythema or ulcers in the oral cavity, and its classification varies according to the scale used. The pathophysiology is associated with risk factors, since the treatment administered and the patient's lifestyle can directly impact the occurrence and progression of OM. Although most cases are mild or moderate, the impact of OM can not be underestimated, even in cases of low symptoms or functional impact, considering oral pain and difficulty in food intake. Thus, it is important that professionals pay attention to the classification, risk factors and possible impacts on health, including the planning of preventive and curative actions in the management of this adverse effect of chemotherapy. Health professionals, including dentists, nurses and doctors must be prepared to deal with cases of OM, promoting integrated actions to reduce the impact of this condition on the health of women with breast cancer.
References
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017). Awareness and current knowledge of breast cancer. Biological research, 50(1), 1-23.
Al-Ansari, S., Zecha, J. A., Barasch, A., de Lange, J., Rozema, F. R., & Raber-Durlacher, J. E. (2015). Oral mucositis induced by anticancer therapies. Current oral health reports, 2(4), 202-211.
Al Ibraheemi, A. A., & Shamoun, S. (2016). Incidence and risk factors of oral mucositis in patients with breast cancer who receiving chemotherapy in Al-Bashir hospital. International journal of hematology-oncology and stem cell research, 10(4), 217.
Araújo, S. N. M., Luz, M. H. B. A., Silva, G. R. F. D., Andrade, E. M. L. R., Nunes, L. C. C., & Moura, R. O. (2015). Cancer patients with oral mucositis: challenges for nursing care. Revista latino-americana de enfermagem, 23(2), 267-274.
Ariyawardana, A., Cheng, K. K. F., Kandwal, A., Tilly, V., Al-Azri, A. R., Galiti, D., ... & Elad, S. (2019). Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 27(10), 3985-3995.
Azamjah, N., Soltan-Zadeh, Y., & Zayeri, F. (2019). Global trend of breast cancer mortality rate: a 25-year study. Asian Pacific journal of cancer prevention: APJCP, 20(7), 2015.
Barasch, A., & Peterson, D. E. (2003). Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral oncology, 39(2), 91-100.
Barbosa-Lima, R., Kameo, S. Y., Amorim, B. F., Ramos, M. J. O., dos Santos Costa, J., Marinho, P. M. L., ... & Silva, G. M. (2020). Occurrence of oral mucositis in women during oncological treatment of breast cancer in the Brazilian Northeast. Health Sciences Journal, 10(4), 144-150.
Brasil. (2019). Estimativa 2020: Incidência de Câncer no Brasil. Instituto Nacional de Câncer - José de Alencar Gomes da Silva. Rio de Janeiro: Ministério da Saúde.
Bonilla, J. M., Tabanera, M. T., & Mendoza, L. R. (2017). Breast cancer in the 21st century: from early detection to new therapies. Radiología (English Edition), 59(5), 368-379.
Chansky, K., Benedetti, J., & Macdonald, J. S. (2005). Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society, 103(6), 1165-1171.
Chaveli-López, B., & Bagán-Sebastián, J. V. (2016). Treatment of oral mucositis due to chemotherapy. Journal of clinical and experimental dentistry, 8(2), e201.
Curra, M., Soares Junior, L. A. V., Martins, M. D., & Santos, P. S. D. S. (2018). Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo), 16(1).
Daugėlaitė, G., Užkuraitytė, K., Jagelavičienė, E., & Filipauskas, A. (2019). Prevention and treatment of chemotherapy and radiotherapy induced oral mucositis. Medicina, 55(2), 25.
Dodd, M. J., Miaskowski, C., Shiba, G. H., Dibble, S. L., Greenspan, D., Macphail, L., ... & Larson, P. (1999). Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history of smoking. Cancer investigation, 17(4), 278-284.
Elad, S., Cheng, K. K. F., Lalla, R. V., Yarom, N., Hong, C., Logan, R. M., ... & Zur, E. (2020). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 126(19), 4423-4431.
Holmes, T. S. V., dos Santos, M. G. C., de Medeiros Nóbrega, D. R., Pereira, J. V., de Castro Gomes, D. Q., & Pereira, M. D. S. V. (2014). Fatores relacionados ao surgimento e gradação da mucosite oral radioinduzida. Rev Cubana Estomatol, 51(1), 45-51.
Hong, B. Y., Sobue, T., Choquette, L., Dupuy, A. K., Thompson, A., Burleson, J. A., ... & Diaz, P. I. (2019). Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome, 7(1), 1-18.
Hong, C. H., Gueiros, L. A., Fulton, J. S., Cheng, K. K. F., Kandwal, A., Galiti, D., ... & Elad, S. (2019). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, 27(10), 3949-3967.
Jesus, L. G. D., Cicchelli, M., Martins, G. B., Pereira, M. C. C., Lima, H. S., & Medrado, A. R. A. P. (2016). Oral effects of anticancer drugs: a literature review. RFO UPF, 21(1), 130-135.
Kusiak, A., AlicjaJereczek-Fossa, B., Cichońska, D., & Alterio, D. (2020). Oncological-therapy related oral mucositis as an interdisciplinary problem—Literature review. International journal of environmental research and public health, 17(7), 2464.
Lalla, R. V., Sonis, S. T., Peterson, D. E (2008). Management of Oral Mucositis in Patients with Cancer. Dent Clin North Am, 52(1), 61-77.
McCarthy, G. M., Awde, J. D., Ghandi, H., Vincent, M., & Kocha, W. I. (1998). Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral oncology, 34(6), 484-490.
Morais, J. R., Vanderley, T. R., Soares, R. D. M., Castro, A. E. D., Araújo, S. N. M., & Luz, M. H. B. A. (2015). Characterization of the patient with chemotherapy-induced oral mucositis/Caracterização do paciente com mucosite oral induzida por quimioterapia/Caracterización de la paciente con mucositis oral inducida por quimioterapia. Revista de Enfermagem da UFPI, 4(1), 26-32.
National Cancer Institute. (2017). Common Terminology Criteria for Adverse Events (CTCAE). United State Department of Health and Human Services, v.5.0.
Park, S. H., & Lee, H. S. (2019). Meta‐analysis of oral cryotherapy in preventing oral mucositis associated with cancer therapy. International journal of nursing practice, 25(5), e12759.
Pereira, I. F., Firmino, R. T., Meira, H. C., Vasconcelos, B. C. D. E., Noronha, V. R. A. D. S., & Santos, V. R. (2019). Radiation-induced oral mucositis in Brazilian patients: Prevalence and associated factors. in vivo, 33(2), 605-609.
Cleverson, P. A. T. U. S. S. I., Laurindo Moacir, S. A. S. S. I., Eduardo Ciliao, M. U. N. H. O. Z., Roberta Targa Stramandinoli, Z. A. N. I. C. O. T. T. I., & Juliana Lucena, S. C. H. U. S. S. E. L. (2014). Clinical assessment of oral mucositis and candidiasis compare to chemotherapic nadir in transplanted patients. Brazilian oral research, 28(1), 1-7.
Pulito, C., Cristaudo, A., La Porta, C., Zapperi, S., Blandino, G., Morrone, A., & Strano, S. (2020). Oral mucositis: the hidden side of cancer therapy. Journal of Experimental & Clinical Cancer Research, 39(1), 1-15.
Raber-durlacher, J. E., Elad, S., Barasch, A. (2010). Oral mucositis. Oral Oncol, 46 (6), 452-456.
Saedi, H. S., Gerami, H., Soltanipour, S., Habibi, A. F., Mirhosseyni, M., Montazeri, S., & Nemati, S. (2019). Frequency of chemoradiotherapy-induced mucositis and related risk factors in patients with the head-and-neck cancers: A survey in the North of Iran. Dental research journal, 16(5), 354.
Scully, C., Sonis, S., Diz, P. D. (2006). Oral mucositis. Oral Dis, 12(3), 229-241.
Seiler, S., Kosse, J., Loibl, S., & Jackisch, C. (2014). Adverse event management of oral mucositis in patients with breast cancer. Breast Care, 9(4), 232-237.
Shankar, A., Roy, S., Bhandari, M., Rath, G. K., Biswas, A. S., Kanodia, R., ... & Sachan, R. (2017). Current trends in management of oral mucositis in cancer treatment. Asian Pacific journal of cancer prevention: APJCP, 18(8), 2019.
Sloan, J. A., Goldberg, R. M., Sargent, D. J., Vargas-Chanes, D., Nair, S., Cha, S. S., ... & Loprinzi, C. L. (2002). Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. Journal of clinical oncology, 20(6), 1491-1498.
Sonis, S. T. (2009). Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral oncology, 45(12), 1015-1020.
Sonis, S. T., Lieberman, A., & Sonis, A. L. (1978). Oral complications in patients receiving treatment for malignancies other than of the head and neck. The Journal of the American Dental Association, 97(3), 468-472.
Sonis, S., & Clark, J. (1991). Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology (Williston Park, NY), 5(12), 11-8.
Suresh, A. V. S., Varma, P. P., Sinha, S., Deepika, S., Raman, R., Srinivasan, M., ... & Anand, B. B. (2010). Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy. Journal of cancer research and therapeutics, 6(4), 448.
Watanabe, T., Kuranami, M., Inoue, K., Masuda, N., Aogi, K., Ohno, S., ... & Ohashi, Y. (2017). Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study. Cancer, 123(5), 759-768.
Wilairat, P., Kengkla, K., Kaewpanan, T., Kaewthong, J., Ruankon, S., Subthaweesin, C., ... & Saokaew, S. (2020). Comparative efficacy and safety of interventions for preventing chemotherapy-induced oral mucositis in adult cancer patients: a systematic review and network meta-analysis. European Journal of Hospital Pharmacy, 27(2), 103-110.
Yu, Y. Y., Deng, J. L., Jin, X. R., Zhang, Z. Z., Zhang, X. H., & Zhou, X. (2020). Effects of 9 oral care solutions on the prevention of oral mucositis: a network meta-analysis of randomized controlled trials. Medicine, 99(16).
Zhang, X., Sun, D., Qin, N., Liu, M., Zhang, J., & Li, X. (2020). Comparative prevention potential of 10 mouthwashes on intolerable oral mucositis in cancer patients: A Bayesian network analysis. Oral oncology, 107, 104751.
Zhang, X. H., Hao, S., Gao, B., Tian, W. G., Jiang, Y., Zhang, S., ... & Luo, D. L. (2016). A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer. Oncotarget, 7(51), 84533-84543.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Pabliane Matias Lordelo Marinho; Ricardo Barbosa-Lima; José Cleyton de Oliveira Santos; Dayane Ketlyn da Cunha Santos; Glebson Santos Sobral; Andressa Cabral Vassilievitch; Bruno Ferreira Amorim; Jéssica dos Santos Costa ; Tiago Vasconcelos Fonseca; Glebson Moura Silva ; Simone Yuriko Kameo; Namie Okino Sawada
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
